• 17 JUL 20
    • 0
    Paper published in Journal of Nuclear Medicine

    Paper published in Journal of Nuclear Medicine

    We are delighted that our safety and imaging feasibility study investigating the fluorescent imaging agent bevacizumab-800CW in soft tissue sarcomas has been published in the Journal of Nuclear Medicine. Based on in- and ex vivo imaging results, 10 mg bevacizumab-800CW is optimal for sarcoma detection and for margin analysis to identify the closest surgical marigin during surgery. The manuscript is accessible HERE

    Leave a reply →